 Ascendis Pharma NASDAQ:ASND has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 0 0 1 Somewhat Bullish 0 2 0 1 Indifferent 0 0 0 Somewhat Bearish 0 0 0 Bearish 0 0 0 5 analysts offering 12-month price targets in the last 3 months for Ascendis Pharma evaluate the company at an average price target of 188.2 with a high of 201.00 and a low of 176.00. 